BIOCRYST PHARMACEUTICALS INC

Ticker: BCRX CUSIP: 09058V103 Class: Common Stock

EntryPoint Capital, LLC's Holding History (CIK: 0001992519)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 12,691 Value ($000) $99 Avg Close $7.23 Range $6.00 - $8.17

Q3 2025

Shares 42,314 Value ($000) $321 Avg Close $8.33 Range $7.42 - $9.23

Q2 2025

Shares 39,025 Value ($000) $350 Avg Close $9.31 Range $6.02 - $11.31

Q1 2025

Shares 40,528 Value ($000) $304 Avg Close $8.07 Range $6.96 - $9.50

Q3 2024

Shares 53,763 Value ($000) $409 Avg Close $7.60 Range $6.17 - $8.88

Q1 2024

Shares 42,679 Value ($000) $217 Avg Close $5.62 Range $4.82 - $7.75

Q4 2023

Shares 5,404 Value ($000) $32 Avg Close $5.79 Range $4.83 - $7.06

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	12,691	$99	$7.23	$6.00 - $8.17
Q3 2025	42,314	$321	$8.33	$7.42 - $9.23
Q2 2025	39,025	$350	$9.31	$6.02 - $11.31
Q1 2025	40,528	$304	$8.07	$6.96 - $9.50
Q3 2024	53,763	$409	$7.60	$6.17 - $8.88
Q1 2024	42,679	$217	$5.62	$4.82 - $7.75
Q4 2023	5,404	$32	$5.79	$4.83 - $7.06